Clinical features | A(n = 31) | B(n = 14) | C(n = 29) | D(n = 54) | E(n = 12) | F(n = 22) |
---|---|---|---|---|---|---|
H. stay, days | 10.87 ± 4.11** | 10.07 ± 4.23 | 7.69 ± 3.24* | 8.09 ± 3.15* | 9.08 ± 3.23 | 7.73 ± 3.88* |
D. of fever, days | 7.39 ± 3.93** | 5.79 ± 4.89 | 4.62 ± 4.07* | 4.80 ± 4.44* | 7.33 ± 5.63 | 4.32 ± 3.20* |
Fever | 30 (96.8%)** | 11 (78.6%)* | 22 (75.9%)* | 43 (79.6%)* | 11 (78.6%)* | 19 (86.4%)* |
Rash | 7 (22.6%) | 0 (0) | 7 (24.1%) | 9 (16.7%) | 1 (8.33%) | 5 (22.7%) |
Lymphadenopathy | 16 (51.6%)** | 7 (50.0%)** | 9 (31.0%)* | 13 (24.1%)* | 3 (25.0%)* | 9 (40.9%) |
Pharyngitis | 31 (100%) | 13 (92.9%) | 28 (96.6%) | 52 (96.3%) | 11 (91.7%) | 22 (100%) |
Palatal petechiae | 6 (19.4%) | 4 (28.6%) | 6 (20.7%) | 8 (14.8%) | 4 (33.3%) | 4 (18.2%) |
Hepatomegaly | 7 (22.6%)* | 3 (21.4%)* | 3 (10.3%)** | 4 (7.41%)** | 0 (0) | 2 (9.09%)** |
Splenomegaly | 3 (9.38%) | 1 (7.41%) | 1 (3.45%) | 2 (3.70%) | 0 (0) | 1 (4.55%) |
ALC > 10% | 8/10 (80.0%)** | 5/10 (50.0%)** | 2/10 (20.0%)* | 8/32 (25.0%)* | 2/7 (28.6%)* | 4/12 (33.3%)* |
Elevated ESR | 14/17 (82.4%)** | 7/9 (77.8%)* | 11/18 (61.1%)* | 15/29 (51.7%)* | 5/5 (100%)** | 8/13 (61.5%)* |
CRP > 10 mg/L | 9/17 (52.9%)* | 5/10 (50.0%)* | 9/18 (50.0%)* | 16/32 (50.0%)* | 7/7 (100%)** | 12/15 (80.0%)** |
ALF | 9/18 (50.0%)* | 3/7 (42.3%)* | 0/7 (0) | 4/17 (23.5%)** | 0/3 (0) | 2/3 (66.7%)* |